Nasal high flow oxygen therapy in hospitalised neonatal foals.
horse
Journal
Equine veterinary journal
ISSN: 2042-3306
Titre abrégé: Equine Vet J
Pays: United States
ID NLM: 0173320
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
26
08
2021
received:
20
11
2020
accepted:
13
09
2021
pubmed:
21
9
2021
medline:
10
8
2022
entrez:
20
9
2021
Statut:
ppublish
Résumé
Respiratory disease is common in critically ill neonatal foals. Traditional oxygen therapy (TOT) with nasal insufflation of oxygen is often used to provide first-line respiratory support. Mechanical ventilation is used in foals which require a greater level of support but requires specialist expertise and can be associated with significant complications. Non-invasive ventilation (NIV) enables a greater level of respiratory support without the need for intubation. High flow oxygen therapy (HFOT) is a mode of NIV commonly used in human intensive care. To describe the use of HFOT in hospitalised neonatal foals. Retrospective case series. Hospital records of neonatal foals admitted between 2018 and 2019 that received treatment with HFOT were reviewed. Clinical data and complications were recorded. Fourteen foals were identified and the median duration of use was 43 hours (range 2-93 hours) with a median flow rate of 0.7L/kg/min (range 0.42-1.67). Ten foals survived to discharge. No significant complications associated with the technique were recorded. A small study population which was retrospectively reviewed. This study provides preliminary information about the clinical use of HFOT in neonatal foals. The technique was well tolerated and no significant adverse effects were noted. However, further study is required to evaluate efficacy.
Sections du résumé
BACKGROUND
BACKGROUND
Respiratory disease is common in critically ill neonatal foals. Traditional oxygen therapy (TOT) with nasal insufflation of oxygen is often used to provide first-line respiratory support. Mechanical ventilation is used in foals which require a greater level of support but requires specialist expertise and can be associated with significant complications. Non-invasive ventilation (NIV) enables a greater level of respiratory support without the need for intubation. High flow oxygen therapy (HFOT) is a mode of NIV commonly used in human intensive care.
OBJECTIVES
OBJECTIVE
To describe the use of HFOT in hospitalised neonatal foals.
STUDY DESIGN
METHODS
Retrospective case series.
METHODS
METHODS
Hospital records of neonatal foals admitted between 2018 and 2019 that received treatment with HFOT were reviewed. Clinical data and complications were recorded.
RESULTS
RESULTS
Fourteen foals were identified and the median duration of use was 43 hours (range 2-93 hours) with a median flow rate of 0.7L/kg/min (range 0.42-1.67). Ten foals survived to discharge. No significant complications associated with the technique were recorded.
MAIN LIMITATIONS
CONCLUSIONS
A small study population which was retrospectively reviewed.
CONCLUSIONS
CONCLUSIONS
This study provides preliminary information about the clinical use of HFOT in neonatal foals. The technique was well tolerated and no significant adverse effects were noted. However, further study is required to evaluate efficacy.
Substances chimiques
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
946-951Informations de copyright
© 2021 EVJ Ltd.
Références
Palmer JE. Ventilatory support of the critically ill foal. Vet Clin North Am Equine Pract. 2005;21:457-86.
Wilkins PA, Palmer JE. Mechanical ventilation in foals with botulism: 9 cases (1989-2002). J Vet Intern Med. 2003;17:708-12.
Keszler M, Sant'Anna G. Mechanical ventilation and bronchopulmonary dysplasia. Clin Perinatol. 2015;42:781-96.
Permall DL, Pasha AB, Chen XQ. Current insights in non-invasive ventilation for the treatment of neonatal respiratory disease. Ital J Pediatr. 2019;45:105.
Raidal SL, McKean R, Ellul PA, Nielsen SG, Quinn CT. Effects of continuous positive airway pressure on respiratory function in sedated foals. J Vet Emerg Crit Care. 2019;29:269-78.
Hong H, Li XX, Li J, Zhang ZQ. High-flow nasal cannula versus nasal continuous positive airway pressure for respiratory support in preterm infants: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2019;24:1-8.
Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39:247-57.
Daly JL, Guenther CL, Haggerty JM, Keir I. Evaluation of oxygen administration with a high-flow nasal cannula to clinically normal dogs. Am J Vet Res. 2017;78:624-30.
Jagodich TA, Bersenas AME, Bateman SW, Kerr CL. High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure in 22 dogs requiring oxygen support escalation. J Vet Emerg Crit Care (San Antonio). 2020;30(4):364-75.
Keir I, Daly J, Haggerty J, Guenther C. Retrospective evaluation of the effect of high flow oxygen therapy delivered by nasal cannula on PaO2 in dogs with moderate-severe hypoxemia. J Vet Emerg Crit Care. 2016;26:598-602.
Pouzot-Nevoret C, Hocine L, Nègre J, Goy-Thollot I, Barthélemy A, Boselli E, et al. Prospective pilot study for evaluation of high-flow oxygen therapy in dyspnoeic dogs: the HOT-DOG study. J Small Anim Pract. 2019;60:656-62.
Alexiou S, Panitch HB. Physiology of non-invasive respiratory support. Semin Fetal Neonatal Med. 2016;21:174-80.
Roberts CT, Hodgson KA. Nasal high flow treatment in preterm infants. Matern Health Neonatol Perinatol. 2017;3:15.
Ritchie JE, Williams AB, Gerard C, Hockey H. Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care. 2011;39(6):1103-10.
Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55:408-13.
Hedge S, Prodhan P. Serious air leak syndrome complicating high-flow nasal cannula therapy: a report of 3 cases. Pediatrics. 2013;131:939-44.